PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Colorectal, or Gastric Cancer
Conditions:  Clinical Stage IV Gastric Cancer AJCC v8;  Clinical Stage IVA Gastric Cancer AJCC v8;  Clinical Stage IVB Gastric Cancer AJCC v8;  Malignant Uterine Neoplasm;  Metastatic Colorectal Carcinoma;  Metastatic Gastric Carcinoma;  Metastatic Malignant Neoplasm in  the Peritoneum;  Metastatic Ovarian Carcinoma;  Pathologic Stage IV Gastric Cancer AJCC v8;  Peritoneal Carcinomatosis;  Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8;  Stage IV Colorectal Cancer AJCC v8;  Stage IV Ovarian Cancer AJCC v8;  Stage IV Ute rine Corpus Cancer AJCC v8;  Stage IVA Colorectal Cancer AJCC v8;  Stage IVA Ovarian Cancer AJCC v8;  Stage IVA Uterine Corpus Cancer AJCC v8;  Stage IVB Colorectal Cancer AJCC v8;  Stage IVB Ovarian Cancer AJCC v8;  Stage IVB Uterine Corpus Cancer AJCC  v8;  Stage IVC Colorectal Cancer AJCC v8 Interventions:  Drug: Cisplatin;  Drug: Doxorubicin;  Drug: Fluorouracil;  Procedure: Intraperitoneal Chemotherapy;  Drug: Leucovorin;  Drug: Oxaliplatin;  Other: Quality-of-Life Assessment;  Other: Questionnaire Administration;  Device: Nebulizer with High-Pressure Injector Sponsors:  City of Hope Medical Center;  National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer of the Uterus | Carcinoma | Chemotherapy | Colorectal Cancer | Eloxatin | Gastric (Stomach) Cancer | Gastroenterology | Ovarian Cancer | Ovaries | Peritoneal Cancer | Research